Senior insider sale
Chief Financial Officer at FILANA THERAPEUTICS, INC. — senior position signals high conviction
$231.0K
59.80K shares
What this filing means
SCHOEN ERIC plans to sell 59.80K shares of FILANA THERAPEUTICS, INC. valued at approximately $231.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/29/2024ACC: 0001972362-24-001778
Officer· Chief Financial Officer
Since Oct 2018
59.80K
Shares to sell
$231.0K
Approx. market value
59.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
STOCK OPTION EXERCISE
COMPENSATION
11/29/2024
50KRETAIL PURCHASE
CASH
8/12/2022
2.50KRETAIL PURCHASE
CASH
12/19/2019
5.30KRETAIL PURCHASE
CASH
5/14/2019
2KTotal acquired59.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/29/2024 | STOCK OPTION EXERCISE COMPENSATION | 50K | — |
8/12/2022 | RETAIL PURCHASE CASH | 2.50K | — |
12/19/2019 | RETAIL PURCHASE CASH | 5.30K | — |
5/14/2019 | RETAIL PURCHASE CASH | 2K | — |
| Total | 59.80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
59.80K
Market value
$231.0K
11/29/2024
Total
Units
59.80K
Value
$231.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/29/2024 | 59.80K | $231.0K | NASDAQ | Planned |
| Total | 59.80K | $231.0K | ||